- Home
- SAGE vs OEC Comparison
SAGE vs OEC Comparison
Compare SAGE & OEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- OEC
- Stock Information
- Founded
- SAGE 2010
- OEC 1862
- Country
- SAGE United States
- OEC Luxembourg
- Employees
- SAGE N/A
- OEC N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- OEC Major Chemicals
- Sector
- SAGE Health Care
- OEC Industrials
- Exchange
- SAGE Nasdaq
- OEC Nasdaq
- Market Cap
- SAGE 571.1M
- OEC 674.8M
- IPO Year
- SAGE 2014
- OEC 2014
- Fundamental
- Price
- SAGE $9.12
- OEC $10.69
- Analyst Decision
- SAGE Hold
- OEC Buy
- Analyst Count
- SAGE 18
- OEC 3
- Target Price
- SAGE $9.89
- OEC $12.33
- AVG Volume (30 Days)
- SAGE 1.8M
- OEC 598.9K
- Earning Date
- SAGE 07-30-2025
- OEC 08-06-2025
- Dividend Yield
- SAGE N/A
- OEC 0.77%
- EPS Growth
- SAGE N/A
- OEC N/A
- EPS
- SAGE N/A
- OEC 0.46
- Revenue
- SAGE $47,404,000.00
- OEC $1,852,300,000.00
- Revenue This Year
- SAGE $101.71
- OEC N/A
- Revenue Next Year
- SAGE $42.30
- OEC $4.72
- P/E Ratio
- SAGE N/A
- OEC $23.44
- Revenue Growth
- SAGE N/A
- OEC N/A
- 52 Week Low
- SAGE $4.62
- OEC $9.59
- 52 Week High
- SAGE $13.47
- OEC $24.85
- Technical
- Relative Strength Index (RSI)
- SAGE 66.62
- OEC 45.61
- Support Level
- SAGE $9.10
- OEC $10.42
- Resistance Level
- SAGE $9.36
- OEC $10.93
- Average True Range (ATR)
- SAGE 0.10
- OEC 0.38
- MACD
- SAGE -0.09
- OEC -0.01
- Stochastic Oscillator
- SAGE 29.69
- OEC 23.46
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About OEC Orion S.A.
Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing and special applications. Geographically, it derives a majority of its revenue from Germany.